My HPRA: Register

The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Nurofen Long Lasting 300 mg Prolonged Release Hard Capsules



Reckitt Benckiser Ireland LtdPA0979/032/015

Main Information

Trade NameNurofen Long Lasting 300 mg Prolonged Release Hard Capsules
Active SubstancesIbuprofen
Dosage FormProlonged-release capsule, hard
Licence HolderReckitt Benckiser Ireland Ltd
Licence NumberPA0979/032/015

Group Information

ATC CodeM01AE Propionic acid derivatives
M01AE01 ibuprofen

Status

License statusAuthorised
Licence Issued13/10/1992
Legal statusProduct not subject to medical prescription
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to the general public
Conditions of LicencePromotion to the public subject to the following restrictions: maximum strength 300 mg, maximum pack size 24, maximum dose: 600 mg, maximum daily dose 1200 mg, limited indications. For use in adults and children over 12 years.
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportPDF Version
« Back
Follow medicine

Print